Cefaly II for migraine prevention
A new version of the Cefaly migraine therapy device is coming to market. The Cefaly II is a much smaller iteration of the first FDA-approved device intended to help prevent the onset of migraines.
The Cefaly delivers transcutaneous electrical stimulation to the trigeminal nerve, which is known to be involved with the pathophysiology of some migraines. Twenty minutes of therapy with the Cefaly has been shown to reduce migraine headaches.